Tactile Systems Technology (TCMD) Cash from Financing Activities (2015 - 2026)
Tactile Systems Technology (TCMD) reported Cash from Financing Activities of -$1.1 million for Q1 2026, up 90.21% year-over-year from -$553593.0 in Q1 2025, and down 238.19% quarter-over-quarter from $762000.0 in Q4 2025.
Tactile Systems Technology (TCMD) Cash from Financing Activities (2015 - 2026) Analysis & Trends
Tactile Systems Technology (TCMD) has 12 years of Cash from Financing Activities data on file, last reported at -$1.1 million in Q1 2026.
- Cash from Financing Activities for Q1 2026 came in at -$1.1 million, up 90.21% year-over-year; the trailing twelve-month figure through Mar 2026 was -$41.5 million (down 179.73% YoY), and the FY2025 annual result was -$51.2 million, down 961.3% from the prior year.
- Cash from Financing Activities retreated to -$1.1 million in Q1 2026 per TCMD's latest filing, from $762000.0 in the prior quarter.
- Over five years, Cash from Financing Activities peaked at $33.9 million in Q1 2023 and troughed at -$24.8 million in Q3 2025.
- A 5-year average of -$3.6 million and a median of -$1.1 million in 2026 frame the typical range for Cash from Financing Activities.
- The sharpest annual moves came in 2023 and 2025: Cash from Financing Activities soared 1016.04% in 2023, then plunged 5676.61% in 2025.
- A 5-year view of Cash from Financing Activities shows it stood at -$5.3 million in 2022, then slumped by 323.96% to -$22.4 million in 2023, then surged by 83.85% to -$3.6 million in 2024, then jumped by 121.05% to $762000.0 in 2025, then slumped by 238.19% to -$1.1 million in 2026.
- Business Quant data shows TCMD's Cash from Financing Activities at -$1.1 million in Q1 2026, $762000.0 in Q4 2025, and -$24.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 157.80 Bn | 151.14 Bn | 6.27 Bn | 17.31 Bn |
| 2 | Stryker | 115.54 Bn | 112.66 Bn | 3.81 Bn | -1.51 Bn |
| 3 | Medtronic | 103.44 Bn | 95.27 Bn | 5.76 Bn | -2.09 Bn |
| 4 | Boston Scientific | 72.38 Bn | 71.17 Bn | 3.61 Bn | -260.00 Mn |
| 5 | Edwards Lifesciences | 49.76 Bn | 46.09 Bn | 1.29 Bn | -451.20 Mn |
| 6 | Dexcom | 29.53 Bn | 28.42 Bn | 750.30 Mn | -25.00 Mn |
| 7 | GE HealthCare Technologies | 29.51 Bn | 27.44 Bn | 1.98 Bn | 21.00 Mn |
| 8 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -26.93 Mn |
| 9 | Steris | 20.69 Bn | 20.27 Bn | 697.10 Mn | -97.90 Mn |
| 10 | Tactile Systems Technology | 573.73 Mn | 483.54 Mn | 57.61 Mn | -1.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.05 Mn |
| Mar 31, 2026 | -1.05 Mn |
| Dec 31, 2025 | 762,000.00 |
| Dec 31, 2025 | 762,000.00 |
| Sep 30, 2025 | -24.75 Mn |
| Sep 30, 2025 | -24.75 Mn |
| Jun 30, 2025 | -16.45 Mn |
| Jun 30, 2025 | -16.45 Mn |
| Mar 31, 2025 | -10.76 Mn |
| Mar 31, 2025 | -10.76 Mn |
| Dec 31, 2024 | -3.62 Mn |
| Dec 31, 2024 | -3.62 Mn |
| Sep 30, 2024 | -750,000.00 |
| Sep 30, 2024 | -750,000.00 |
| Jun 30, 2024 | 295,000.00 |
| Jun 30, 2024 | 295,000.00 |
| Mar 31, 2024 | -749,000.00 |
| Mar 31, 2024 | -749,000.00 |
| Dec 31, 2023 | -22.42 Mn |
| Dec 31, 2023 | -22.42 Mn |